https://www.panel.docpromote.com/files/media/10/media__elkgrovegeneric_c74e63d656.jpg

New exciting advance in Melanoma Treatment

Blog

New exciting advance in Melanoma Treatment

https://www.panel.docpromote.com/files/media/10/media__idielkgrovemelanomacondition_bf8f70e92f.jpg

New exciting advance in Melanoma Treatment

The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes.

“Melanoma is a serious disease that can advance and spread to other parts of the body, where it becomes difficult to treat,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research. “This approval provides patients and health care providers with a novel treatment for melanoma.” Skin cancer is the most common form of cancer in the United States. Melanoma, one type of skin cancer, is the leading cause of skin cancer related deaths, and is most often caused by exposure to ultraviolet (UV) light. According to the National Cancer Institute approximately 74,000 Americans will be diagnosed with melanoma and nearly 10,000 will die from the disease in 2015….”

SOURCE: U.S. Food and Drug Administration, news release, Oct. 27, 2015

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm469571.htm